Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Wave Life Sciences (WVE) Return on Invested Capital (2016 - 2024)

Wave Life Sciences' Return on Invested Capital history spans 10 years, with the latest figure at 7.57% for Q2 2024.

  • For Q2 2024, Return on Invested Capital fell 1074.0% year-over-year to 7.57%; the TTM value through Jun 2024 reached 7.57%, down 1074.0%, while the annual FY2023 figure was 24.61%, 134.0% down from the prior year.
  • Return on Invested Capital reached 7.57% in Q2 2024 per WVE's latest filing, down from 2.2% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 156.96% in Q4 2023 to a low of 11.73% in Q3 2022.
  • Average Return on Invested Capital over 5 years is 7.95%, with a median of 2.2% recorded in 2024.
  • Peak YoY movement for Return on Invested Capital: surged 15037bps in 2023, then plummeted -1074bps in 2024.
  • A 5-year view of Return on Invested Capital shows it stood at 1.6% in 2020, then crashed by -155bps to 4.06% in 2021, then surged by 262bps to 6.59% in 2022, then soared by 2283bps to 156.96% in 2023, then tumbled by -105bps to 7.57% in 2024.
  • Per Business Quant, the three most recent readings for WVE's Return on Invested Capital are 7.57% (Q2 2024), 2.2% (Q1 2024), and 156.96% (Q4 2023).